Critical decisions are taken during protocol design. It is essential to maintain patient centricity and respect site constraints, but it is also an opportunity to evaluate the supply impact. Different scenarios can be investigated with an advanced simulation and optimization tool that accurately models both the clinical design and the supply aspects of the protocol. […]

For decades, risk in clinical trial supply has been mitigated by maintaining buffers of drug available throughout the supply chain. Buffers are necessary to cover the inherent variability in the demand of clinical trials. When not consumed by patients during the trial, these buffers result in unused drug, or “overage”. When investigational medicines are readily available and not expensive, having higher overage in a study can be accepted by the company in order to ensure no risk to patient service level.

Visualize your data to manage your clinical trial at a glance and facilitate your decisions.   N-SIDE is happy to launch the new Clinical Trial Management Dashboards. Our business intelligence analytics leverage all of CT-FAST clinical trial forecasts, IRT study data and project information, turning data into insights. Make informed decisions and quickly visualize your […]